These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 39120312)

  • 1. Therapy-Induced Cellular Senescence: Potentiating Tumor Elimination or Driving Cancer Resistance and Recurrence?
    Liu Y; Lomeli I; Kron SJ
    Cells; 2024 Jul; 13(15):. PubMed ID: 39120312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy-Induced Senescence: Novel Approaches for Markers Identification.
    Pacifico F; Magni F; Leonardi A; Crescenzi E
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Jekyll and Hyde of Cellular Senescence in Cancer.
    Demirci D; Dayanc B; Mazi FA; Senturk S
    Cells; 2021 Jan; 10(2):. PubMed ID: 33494247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
    Chambers CR; Ritchie S; Pereira BA; Timpson P
    Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of senescence on the tumour microenvironment and response to therapy.
    Reynolds LE; Maallin S; Haston S; Martinez-Barbera JP; Hodivala-Dilke KM; Pedrosa AR
    FEBS J; 2024 Jun; 291(11):2306-2319. PubMed ID: 37873605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senescence and the tumor-immune landscape: Implications for cancer immunotherapy.
    Chibaya L; Snyder J; Ruscetti M
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):827-845. PubMed ID: 35143990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular senescence and the tumour microenvironment.
    Takasugi M; Yoshida Y; Ohtani N
    Mol Oncol; 2022 Sep; 16(18):3333-3351. PubMed ID: 35674109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging.
    Muñoz DP; Yannone SM; Daemen A; Sun Y; Vakar-Lopez F; Kawahara M; Freund AM; Rodier F; Wu JD; Desprez PY; Raulet DH; Nelson PS; van 't Veer LJ; Campisi J; Coppé JP
    JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies.
    D'Ambrosio M; Gil J
    Dev Cell; 2023 Jun; 58(12):1007-1021. PubMed ID: 37339603
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Zhang JW; Zhang D; Yin HS; Zhang H; Hong KQ; Yuan JP; Yu BP
    Gut Microbes; 2023; 15(1):2197836. PubMed ID: 37017266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senescence in the Development and Response to Cancer with Immunotherapy: A Double-Edged Sword.
    Battram AM; Bachiller M; Martín-Antonio B
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-γ and TNF Induce Senescence and a Distinct Senescence-Associated Secretory Phenotype in Melanoma.
    Homann L; Rentschler M; Brenner E; Böhm K; Röcken M; Wieder T
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells.
    Chaturvedi P; George V; Shrestha N; Wang M; Dee MJ; Zhu X; Liu B; Egan J; D'Eramo F; Spanoudis C; Gallo V; Echeverri C; You L; Kong L; Fang B; Jeng EK; Rhode PR; Wong HC
    Mol Ther; 2022 Mar; 30(3):1171-1187. PubMed ID: 35051615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophages and tumor-associated macrophages in the senescent microenvironment: From immunosuppressive TME to targeted tumor therapy.
    Du M; Sun L; Guo J; Lv H
    Pharmacol Res; 2024 Jun; 204():107198. PubMed ID: 38692466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy.
    Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M
    Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting senescence-associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes.
    Xiong J; Dong L; Lv Q; Yin Y; Zhao J; Ke Y; Wang S; Zhang W; Wu M
    Clin Transl Med; 2024 Sep; 14(9):e1772. PubMed ID: 39270064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of Radiation-Induced Senescence in the Brain Tumor Microenvironment Attenuates Glioblastoma Recurrence.
    Fletcher-Sananikone E; Kanji S; Tomimatsu N; Di Cristofaro LFM; Kollipara RK; Saha D; Floyd JR; Sung P; Hromas R; Burns TC; Kittler R; Habib AA; Mukherjee B; Burma S
    Cancer Res; 2021 Dec; 81(23):5935-5947. PubMed ID: 34580063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
    Luo Y; Liu H; Fu H; Ding GS; Teng F
    Front Immunol; 2022; 13():974377. PubMed ID: 36458010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).
    Malaquin N; Tu V; Rodier F
    Methods Mol Biol; 2019; 1896():45-55. PubMed ID: 30474839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cellular senescence and SASP in tumour microenvironment.
    Takasugi M; Yoshida Y; Hara E; Ohtani N
    FEBS J; 2023 Mar; 290(5):1348-1361. PubMed ID: 35106956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.